Remove 2028 Remove Disease Remove Packaging
article thumbnail

Article Periodic Thank You European Commission issues EU-wide rules on pesticide ingredients

Agency IQ

The PPPR framework governs the authorization, sale, and use of PPPs, establishing a pre-market approval process for active substances – the pesticide components which control pests, weeds, and plant diseases – and for synergists and safeners before they can be allowed for use in PPPs.

article thumbnail

Article EMA Thank You New guidance provides definition for orphan device, offers alternative trial designs

Agency IQ

The working definition offered at that meeting focused on devices intended to treat or diagnose patients for diseases or conditions affecting no more than 1 in 37,000 Europeans per year. Those criteria are that the device is intended to benefit patients with a disease or condition present in 12,000 or fewer people in the E.U.

Trials 40
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

State-Led Food Transparency: Texas and Louisiana Lead the Charge

FDA Law Blog: Biosimilars

This labeling requirement will apply to packages “developed or copyrighted” from January 1, 2027 onward. The QR codes and digital disclosures must be included on the outer product packaging by January 1, 2028. The law applies to all foods, even if produced outside of the state. Preservatives such as BHA and BHT. Synthetic dyes.

article thumbnail

Flurpiridaz F 18

New Drug Approvals

2] [3] History Flurpiridaz F-18 is a fluorine 18-labeled agent developed by Lantheus Medical Imaging for the diagnosis of coronary artery disease. [7] 2] [3] History Flurpiridaz F-18 is a fluorine 18-labeled agent developed by Lantheus Medical Imaging for the diagnosis of coronary artery disease. [7] mmol) and Na 2 CO 3 (0.33

FDA 57